Coates M. S., D. F. Fletcher, H-K. Chan and J. A. Raper,
(2004) Effect of Design on the Performance of a Dry
Powder Inhaler Using Computational Fluid Dynamics.
Part 1: Grid Structure and Mouthpiece Length, J. of
Pharmaceutical Sciences, 93, 2863–2876.
Coates M. S., H-K Chan, D. F. Fletcher and J. A. Raper,
(2005) Influence of Air Flow on the Performance of a
Dry Powder Inhaler Using Computational and
Experimental Analyses, Pharmaceutical Research,
22(9), 923-932.
Coates M. S., H-K. Chan, D. F. Fletcher and J. A. Raper,
(2006) Effect of Design on the Performance of a Dry
Powder Inhaler Using Computational Fluid Dynamics.
Part 2: Air Inlet Size, J. of Pharmaceutical Sciences,
95(6), 1382-1392.
de Koning J. P., M. R. Visser, G. A. Oelen, A. H. de Boer,
ThW van der Mark, P. M. J. Coenegracht, ThFJ
Tromp and H. W. Frijlink, (2001) Effect of Peak
Inspiratory Flow and Flow Increase Rate on In Vitro
Drug Deposition from Four Dry Powder Inhaler
Devices, in Dry Powder Inhalation: Technical and
Physiological Aspects, Prescribing and Use, Thesis,
Rijksuniversiteit Groningen, Ch. 6., 83-94.
Finlay W., (2001) The Mechanics of Inhaled
Pharmaceutical Aerosols. An Introduction, Academic
Press, London.
French D. L., D. A. Edwards and R. W. Niven, (1996) The
Influence of Formulation on Emission Deaggregation
and Deposition of Dry Powders for Inhalation, J.
Aerosol Sci., 27(5), 769-783.
Hoe S., D. Traini, H-K. Chan, P. M. Young, (2009)
Measuring charge and mass distributions in dry
powder inhalers using the electrical Next Generation
Impactor (eNGI), European J. of Pharmaceutical
Science, 38, 88-94.
Islam N. and E. Gladki, (2008) Dry powder inhalers
(DPIs) - A review of device reliability and innovation,
Int. J. of Pharmaceutics, 360, 1-11.
Ligotke M. W., (2002) Development and characterization
of a dry powder inhaler. In: Dalby RN, Byron PR,
Peart J, Farr SJ, editors. Respiratory drug delivery
VIII, vol. I. Tucson, AZ: Serentec Press Inc., 419–422.
Newman S. P. and W.W. Busse, (2002) Evolution of dry
powder inhaler design, formulation, and performance,
Respir Med., 96(5), 293-304.
Olsson et al.: Patent Application Publication. Pub. No. US
2007/0107721 A1. Pub. Date: May, 17, 2007.
Schuler C., A. Bakshi, D. Tuttle, A. Smith, S. Paboojian,
H. Snyder, D. Rasmussen, A. Clark, (1999) Inhale’s
dry-powder pulmonary drug delivery system:
Challenges to current modeling of gas-solid flows. In:
Proceedings of FEDSM99: 3rd ASME/JSME joint
fluids engineering conference and 1999 ASME Fluids
Engineering summer meeting, FEDSM99-7895.
Tobyn M., J. N. Staniforth, D. Morton, Q. Harmer and M.
E. Newton, (2004) Active and intelligent inhaler
device development, Int. J. of Pharmaceutics 277, 31–
37.
Tong Z. B., R. Y. Yang, K. W. Chu, A. B. Yu, S. Adi, H-
K. Chan, (2010) Numerical study of the effects of
particle size and polydispersity on the agglomerate
dispersion in a cyclonic flow, Chemical Engineering
Journal 164, 432–441.
Tsima M. P., G. P. Martin, C. Marriott, D. Gardenton and
M. Yianneskis, (1994) Drug delivery to the respiratory
tract using dry powder inhaler, Int. J. of
Pharmaceutics, 101, 1-13.
Wetterlin K., (1988) Turbuhaler: A New Powder Inhaler
for Administration of Drugs to the Airways.
Pharmaceutical Research, 5(8), 506-508.
Zeng X-M, G. P. Martin, C. Marriott and J. Pritchard,
(2000) The influence of carrier morphology on drug
delivery by dry powder inhalers, Int. J. of
Pharmaceutics, 200, 93–106.
AirflowandParticleDepositioninaDryPowderInhaler-ACFDSimulation
259